Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

The NOD-scid IL2rγnull Mouse Model Is Suitable for the Study of Osteoarticular Brucellosis and Vaccine Safety.

Khalaf OH, Chaki SP, Garcia-Gonzalez DG, Ficht TA, Arenas-Gamboa AM.

Infect Immun. 2019 May 21;87(6). pii: e00901-18. doi: 10.1128/IAI.00901-18. Print 2019 Jun.

PMID:
30936160
2.

Quantitative Yeast Genetic Interaction Profiling of Bacterial Effector Proteins Uncovers a Role for the Human Retromer in Salmonella Infection.

Patrick KL, Wojcechowskyj JA, Bell SL, Riba MN, Jing T, Talmage S, Xu P, Cabello AL, Xu J, Shales M, Jimenez-Morales D, Ficht TA, de Figueiredo P, Samuel JE, Li P, Krogan NJ, Watson RO.

Cell Syst. 2018 Sep 26;7(3):323-338.e6. doi: 10.1016/j.cels.2018.06.010. Epub 2018 Aug 1.

3.

Activation of Host IRE1α-Dependent Signaling Axis Contributes the Intracellular Parasitism of Brucella melitensis.

Pandey A, Lin F, Cabello AL, da Costa LF, Feng X, Feng HQ, Zhang MZ, Iwawaki T, Rice-Ficht A, Ficht TA, de Figueiredo P, Qin QM.

Front Cell Infect Microbiol. 2018 Apr 20;8:103. doi: 10.3389/fcimb.2018.00103. eCollection 2018.

4.

Human Brucellosis and Adverse Pregnancy Outcomes.

Arenas-Gamboa AM, Rossetti CA, Chaki SP, Garcia-Gonzalez DG, Adams LG, Ficht TA.

Curr Trop Med Rep. 2016 Dec;3(4):164-172. doi: 10.1007/s40475-016-0092-0. Epub 2016 Oct 1.

5.

AOAC SMPR 2016.009.

Roberto F, Arce J, Beck LC, Blank TR, Cahall R, Damer K, Ficht T, Foster J, Kiss K, Nikolich M, Olsen S, Ozanich R, Rozak D, Schaefer F, Sozhamannan S, Tiller R, Coates SG.

J AOAC Int. 2017 Jan 1;100(1):255-260. doi: 10.5740/jaoacint.SMPR2016.009. No abstract available.

PMID:
28825552
6.

Mucosal bacterial dissemination in a rhesus macaque model of experimental brucellosis.

Russell-Lodrigue KE, Killeen SZ, Ficht TA, Roy CJ.

J Med Primatol. 2018 Feb;47(1):75-77. doi: 10.1111/jmp.12282. Epub 2017 Jun 2.

7.

Global Reprogramming of Host Kinase Signaling in Response to Fungal Infection.

Pandey A, Ding SL, Qin QM, Gupta R, Gomez G, Lin F, Feng X, Fachini da Costa L, Chaki SP, Katepalli M, Case ED, van Schaik EJ, Sidiq T, Khalaf O, Arenas A, Kobayashi KS, Samuel JE, Rivera GM, Alaniz RC, Sze SH, Qian X, Brown WJ, Rice-Ficht A, Russell WK, Ficht TA, de Figueiredo P.

Cell Host Microbe. 2017 May 10;21(5):637-649.e6. doi: 10.1016/j.chom.2017.04.008.

8.

A Brucella spp. Isolate from a Pac-Man Frog (Ceratophrys ornata) Reveals Characteristics Departing from Classical Brucellae.

Soler-Lloréns PF, Quance CR, Lawhon SD, Stuber TP, Edwards JF, Ficht TA, Robbe-Austerman S, O'Callaghan D, Keriel A.

Front Cell Infect Microbiol. 2016 Sep 28;6:116. eCollection 2016.

9.

The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis.

Pandey A, Cabello A, Akoolo L, Rice-Ficht A, Arenas-Gamboa A, McMurray D, Ficht TA, de Figueiredo P.

PLoS Negl Trop Dis. 2016 Aug 18;10(8):e0004572. doi: 10.1371/journal.pntd.0004572. eCollection 2016 Aug. Review.

10.

Space: A Final Frontier for Vacuolar Pathogens.

Case ED, Smith JA, Ficht TA, Samuel JE, de Figueiredo P.

Traffic. 2016 May;17(5):461-74. doi: 10.1111/tra.12382. Epub 2016 Feb 24. Review.

11.

Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.

de Figueiredo P, Ficht TA, Rice-Ficht A, Rossetti CA, Adams LG.

Am J Pathol. 2015 Jun;185(6):1505-17. doi: 10.1016/j.ajpath.2015.03.003. Epub 2015 Apr 17. Review.

12.

SiRNA screens using Drosophila cells to identify host factors required for infection.

Pandey A, Ding SL, Ficht TA, de Figueiredo P.

Methods Mol Biol. 2014;1197:229-44. doi: 10.1007/978-1-4939-1261-2_13.

PMID:
25172284
13.

Brucella dissociation is essential for macrophage egress and bacterial dissemination.

Pei J, Kahl-McDonagh M, Ficht TA.

Front Cell Infect Microbiol. 2014 Mar 5;4:23. doi: 10.3389/fcimb.2014.00023. eCollection 2014.

14.

Aerosol-induced brucellosis increases TLR-2 expression and increased complexity in the microanatomy of astroglia in rhesus macaques.

Lee KM, Chiu KB, Sansing HA, Didier PJ, Ficht TA, Arenas-Gamboa AM, Roy CJ, Maclean AG.

Front Cell Infect Microbiol. 2013 Dec 2;3:86. doi: 10.3389/fcimb.2013.00086. eCollection 2013.

15.

Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.

Gomez G, Adams LG, Rice-Ficht A, Ficht TA.

Front Cell Infect Microbiol. 2013 May 16;3:17. doi: 10.3389/fcimb.2013.00017. eCollection 2013. Review.

16.

Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approach.

Gomez G, Pei J, Mwangi W, Adams LG, Rice-Ficht A, Ficht TA.

PLoS One. 2013;8(3):e59751. doi: 10.1371/journal.pone.0059751. Epub 2013 Mar 22.

17.

Diverse genetic regulon of the virulence-associated transcriptional regulator MucR in Brucella abortus 2308.

Caswell CC, Elhassanny AE, Planchin EE, Roux CM, Weeks-Gorospe JN, Ficht TA, Dunman PM, Roop RM 2nd.

Infect Immun. 2013 Apr;81(4):1040-51. doi: 10.1128/IAI.01097-12. Epub 2013 Jan 14.

18.

Serologic response in bottlenose dolphins Tursiops truncatus infected with Brucella sp. using a dolphin-specific indirect ELISA.

Meegan J, Dunn JL, Venn-Watson SK, Smith CR, Sidor I, Jensen ED, Van Bonn WG, Pugh R, Ficht T, Adams LG, Nielsen K, Romano TA.

Dis Aquat Organ. 2012 Dec 3;102(1):73-85. doi: 10.3354/dao02528.

19.

Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.

Pei J, Ding X, Fan Y, Rice-Ficht A, Ficht TA.

Front Cell Infect Microbiol. 2012 Sep 7;2:115. doi: 10.3389/fcimb.2012.00115. eCollection 2012.

20.

Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.

Arenas-Gamboa AM, Rice-Ficht AC, Fan Y, Kahl-McDonagh MM, Ficht TA.

Clin Vaccine Immunol. 2012 Feb;19(2):249-60. doi: 10.1128/CVI.05321-11. Epub 2011 Dec 14.

21.

Bacterial Exchange via Nanotubes: Lessons Learned from the History of Molecular Biology.

Ficht TA.

Front Microbiol. 2011 Sep 8;2:179. doi: 10.3389/fmicb.2011.00179. eCollection 2011.

22.

Lipopolysaccharide-Deficient Brucella Variants Arise Spontaneously during Infection.

Turse JE, Pei J, Ficht TA.

Front Microbiol. 2011 Mar 23;2:54. doi: 10.3389/fmicb.2011.00054. eCollection 2011.

23.

Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.

Arenas-Gamboa AM, Rice-Ficht AC, Kahl-McDonagh MM, Ficht TA.

Infect Immun. 2011 Sep;79(9):3653-8. doi: 10.1128/IAI.05330-11. Epub 2011 Jun 27. Erratum in: Infect Immun. 2011 Dec;79(12):5040.

24.

Functional analysis of host factors that mediate the intracellular lifestyle of Cryptococcus neoformans.

Qin QM, Luo J, Lin X, Pei J, Li L, Ficht TA, de Figueiredo P.

PLoS Pathog. 2011 Jun;7(6):e1002078. doi: 10.1371/journal.ppat.1002078. Epub 2011 Jun 16.

25.

Amplified fragment length polymorphism reveals specific epigenetic distinctions between Mycobacterium avium subspecies paratuberculosis isolates of various isolation types.

O'Shea B, Khare S, Klein P, Roussel A, Adams LG, Ficht TA, Rice-Ficht AC.

J Clin Microbiol. 2011 Jun;49(6):2222-9. doi: 10.1128/JCM.01123-10. Epub 2011 Apr 6.

26.

Lipopolysaccharide: a complex role in the pathogenesis of brucellosis.

Pei J, Ficht TA.

Vet J. 2011 Jul;189(1):5-6. doi: 10.1016/j.tvjl.2010.07.009. Epub 2010 Aug 10. No abstract available.

PMID:
20702124
27.

In vitro mutagenesis of Brucella species.

Ficht TA, Pei J, Kahl-McDonagh M.

Methods Mol Biol. 2010;634:15-35. doi: 10.1007/978-1-60761-652-8_2.

PMID:
20676973
28.

DNA watermarking of infectious agents: progress and prospects.

Jupiter DC, Ficht TA, Samuel J, Qin QM, de Figueiredo P.

PLoS Pathog. 2010 Jun 17;6(6):e1000950. doi: 10.1371/journal.ppat.1000950. No abstract available.

29.

Brucella melitensis VjbR and C12-HSL regulons: contributions of the N-dodecanoyl homoserine lactone signaling molecule and LuxR homologue VjbR to gene expression.

Weeks JN, Galindo CL, Drake KL, Adams GL, Garner HR, Ficht TA.

BMC Microbiol. 2010 Jun 8;10:167. doi: 10.1186/1471-2180-10-167.

30.

Brucella taxonomy and evolution.

Ficht T.

Future Microbiol. 2010 Jun;5(6):859-66. doi: 10.2217/fmb.10.52. Review. Erratum in: Future Microbiol. 2010 Aug;5(8):1299.

31.

Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.

Liang L, Leng D, Burk C, Nakajima-Sasaki R, Kayala MA, Atluri VL, Pablo J, Unal B, Ficht TA, Gotuzzo E, Saito M, Morrow WJ, Liang X, Baldi P, Gilman RH, Vinetz JM, Tsolis RM, Felgner PL.

PLoS Negl Trop Dis. 2010 May 4;4(5):e673. doi: 10.1371/journal.pntd.0000673.

32.

Polymeric particles in vaccine delivery.

Rice-Ficht AC, Arenas-Gamboa AM, Kahl-McDonagh MM, Ficht TA.

Curr Opin Microbiol. 2010 Feb;13(1):106-12. doi: 10.1016/j.mib.2009.12.001. Epub 2010 Jan 14. Review.

PMID:
20079678
33.

Genomic polymorphisms as inherent watermarks for tracking infectious agents.

Jupiter D, Ficht T, Qin QM, Rice-Ficht A, Samuel J, de Figueiredo P.

Front Microbiol. 2010 Sep 30;1:109. doi: 10.3389/fmicb.2010.00109. eCollection 2010. No abstract available.

34.

Oral vaccination with microencapsuled strain 19 vaccine confers enhanced protection against Brucella abortus strain 2308 challenge in red deer (Cervus elaphus elaphus).

Arenas-Gamboa AM, Ficht TA, Davis DS, Elzer PH, Kahl-McDonagh M, Wong-Gonzalez A, Rice-Ficht AC.

J Wildl Dis. 2009 Oct;45(4):1021-9.

PMID:
19901378
35.

Brucellosis: the case for live, attenuated vaccines.

Ficht TA, Kahl-McDonagh MM, Arenas-Gamboa AM, Rice-Ficht AC.

Vaccine. 2009 Nov 5;27 Suppl 4:D40-3. doi: 10.1016/j.vaccine.2009.08.058. Review.

36.

Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle.

Wattam AR, Williams KP, Snyder EE, Almeida NF Jr, Shukla M, Dickerman AW, Crasta OR, Kenyon R, Lu J, Shallom JM, Yoo H, Ficht TA, Tsolis RM, Munk C, Tapia R, Han CS, Detter JC, Bruce D, Brettin TS, Sobral BW, Boyle SM, Setubal JC.

J Bacteriol. 2009 Jun;191(11):3569-79. doi: 10.1128/JB.01767-08. Epub 2009 Apr 3.

37.

Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheres.

Arenas-Gamboa AM, Ficht TA, Davis DS, Elzer PH, Wong-Gonzalez A, Rice-Ficht AC.

J Wildl Dis. 2009 Jan;45(1):165-73.

38.

The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.

Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Gomez G, Rice-Ficht AC.

Infect Immun. 2009 Feb;77(2):877-84. doi: 10.1128/IAI.01017-08. Epub 2008 Dec 1.

39.

Laboratory maintenance of Brucella abortus.

Sun YH, den Hartigh AB, Tsolis RM, Ficht TA.

Curr Protoc Microbiol. 2005 Oct;Chapter 3:Unit 3B.1. doi: 10.1002/9780471729259.mc03b01s00.

PMID:
18770565
40.

RNAi screen of endoplasmic reticulum-associated host factors reveals a role for IRE1alpha in supporting Brucella replication.

Qin QM, Pei J, Ancona V, Shaw BD, Ficht TA, de Figueiredo P.

PLoS Pathog. 2008 Jul 25;4(7):e1000110. doi: 10.1371/journal.ppat.1000110.

41.

Evidence of Brucella abortus OPS dictating uptake and restricting NF-kappaB activation in murine macrophages.

Pei J, Turse JE, Ficht TA.

Microbes Infect. 2008 May;10(6):582-90. doi: 10.1016/j.micinf.2008.01.005. Epub 2008 Jan 20.

42.

Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.

Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Rice-Ficht AC.

Infect Immun. 2008 Jun;76(6):2448-55. doi: 10.1128/IAI.00767-07. Epub 2008 Mar 24.

43.

VirB12 is a serological marker of Brucella infection in experimental and natural hosts.

Rolán HG, den Hartigh AB, Kahl-McDonagh M, Ficht T, Adams LG, Tsolis RM.

Clin Vaccine Immunol. 2008 Feb;15(2):208-14. Epub 2007 Dec 12.

44.

Cytotoxicity in macrophages infected with rough Brucella mutants is type IV secretion system dependent.

Pei J, Wu Q, Kahl-McDonagh M, Ficht TA.

Infect Immun. 2008 Jan;76(1):30-7. Epub 2007 Oct 15.

45.

Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.

Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA.

Infect Immun. 2007 Oct;75(10):4923-32. Epub 2007 Jul 30.

46.
48.

Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.

Kahl-McDonagh MM, Elzer PH, Hagius SD, Walker JV, Perry QL, Seabury CM, den Hartigh AB, Tsolis RM, Adams LG, Davis DS, Ficht TA.

Vaccine. 2006 Jun 12;24(24):5169-77. Epub 2006 Apr 27.

PMID:
16697090
50.

Differential requirements for VirB1 and VirB2 during Brucella abortus infection.

den Hartigh AB, Sun YH, Sondervan D, Heuvelmans N, Reinders MO, Ficht TA, Tsolis RM.

Infect Immun. 2004 Sep;72(9):5143-9.

Supplemental Content

Support Center